No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure

被引：5
|
作者：
Hsieh, Meng-Jer
Yu, Chun-Chen
Hu, Han-Chung
Thai, Ying-Huang
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Pneumonia; Vaccination; Chronic disease;
D O I：
10.1183/13993003.congress-2016.PA612
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA612
引用
收藏
页数：2
相关论文
共 50 条
  • [41] INFLUENCE OF VARIOUS FACTORS ON THE IMMUNOGENICITY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 614 - 615
  • [42] IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH IMMUNO-INFLAMMATORY RHEUMATIC DISEASES
    Muravyeva, N. V.
    Belov, B. S.
    Naumtseva, M. S.
    Baranova, M. M.
    Cherkasova, M. V.
    Korotaeva, T. V.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S348 - S348
  • [43] Safety and immunogenicity of a single dose 23-valent pneumococcal polysaccharide vaccine in Russian subjects
    Ciprero, Karen
    Zykov, Kirill A.
    Briko, Nikolay I.
    Shekar, Tulin
    Sterling, Tina M.
    Bitieva, Elizaveta
    Stek, Jon E.
    Musey, Luwy
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (08) : 2142 - 2147
  • [44] Evaluation of appropriateness of vaccination procedures of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in a hospital setting
    Coleman, Paige
    Sears, Matthew
    Vaichys, Sabina
    Nemecek, Branden
    Guarascio, Anthony
    PHARMACOTHERAPY, 2015, 35 (11): : E305 - E305
  • [45] Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly
    Ortqvist, A.
    Henckaerts, I.
    Hedlund, J.
    Poolman, J.
    VACCINE, 2007, 25 (13) : 2445 - 2450
  • [46] USE OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: THE RELATIONSHIP OF IMMUNOGENICITY WITH THERAPY
    Tarasova, Galina
    Belov, Boris
    Bukhanova, Daria
    Cherkasova, Maria
    Solovyev, Sergey
    Aseeva, Elena
    Reshetnyak, Tatiana
    Popkova, Tatiana
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 785 - 786
  • [47] A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine
    Laratta, C. R.
    Williams, K.
    Vethanayagam, D.
    Ulanova, M.
    Vliagoftis, H.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2017, 13
  • [48] Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populations
    Wang, Yang
    Li, Jingxin
    Wang, Yuxiao
    Gu, Wei
    Zhu, Fengcai
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (04) : 1003 - 1012
  • [49] Invasive pneumococcal disease epidemiology and effectiveness of 23-valent pneumococcal polysaccharide vaccine in Alaska Native adults
    Singleton, Rosalyn J.
    Butler, Jay C.
    Bulkow, Lisa R.
    Hurlburt, Debby
    O'Brien, Katherine L.
    Doan, William
    Parkinson, Alan J.
    Hennessy, Thomas W.
    VACCINE, 2007, 25 (12) : 2288 - 2295
  • [50] HETEROGENEITY OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY DUE TO VARIOUS UNDERLYING CONDITIONS OF CHRONIC PULMONARY DISEASE IN ELDERLY PATIENTS
    Inoue, S.
    Kaneko, T.
    Morita, S.
    Natsumeda, Y.
    Mizushima, S.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A115 - A115
12345